Rhabdomyolysis
Conditions
Keywords
battlefield acupuncture, rhabdomyolysis, pain management
Brief summary
Patients admitted with exertional rhabdomyolysis will be offered treatment with battlefield acupuncture for pain management and compared with patient's pain levels and pain medication requirements with those patients who declined battlefield acupuncture.
Detailed description
Pilot study using a prospective observational case series of patients admitted to Tripler Army Medical Center who meet CHAMP criteria for rhabdomyolysis and who elect to undergo BFA in addition to standard of care pain control. We will not blind patients, providers, or research coordinators. Goal is to administer BFA within 12 hours of inpatient admission and monitor the pain response.
Interventions
PROCEDUREBattlefield Acupuncture
Treatment of pain from rhabdomyolysis with battlefield acupuncture
Sponsors
Tripler Army Medical Center
Study design
Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
18 Years to 99 Years
Healthy volunteers
Yes
Inclusion criteria
* Rhabdomyolysis * chooses battlefield acupuncture
Exclusion criteria
* Greater than 72 hours from onset of symptoms * younger than 18 years of age * declines battlefield acupuncture * no pain
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Pain Level on a pain scale of 0-10 | Pain level will be measured through study completion (up to 12 months). | Reported pain levels on a subjective pain score of 0-10 |
| Pain Medication | From enrollment to the end of treatment at 12 months | Amount of pain medication required, Morphine equivalent and acetaminophen use on hospital days 1-7 |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Length of Hospital Stay in days | Length of time from admission to discharge in days (up to 7 days) | How long the patient stays in the hospital in days |
Countries
United States
Contacts
CONTACTChelsea W Tagawa, MD
CONTACTSusan A Scrivner, MS
PRINCIPAL_INVESTIGATORChelsea W Tagawa, MD
Tripler Army Medical Center
Outcome results
None listed